Today: 28 June 2026
Browse Category

NYSE:KMB 22 October 2025 - 19 December 2025

Kenvue Stock (KVUE) News Today: Deal Spread Math, Kimberly-Clark Vote Timeline, Tylenol Lawsuits, and Analyst Forecasts (Dec. 19, 2025)

Kenvue Stock (KVUE) News Today: Deal Spread Math, Kimberly-Clark Vote Timeline, Tylenol Lawsuits, and Analyst Forecasts (Dec. 19, 2025)

Kenvue shares closed at $17.10 on Dec. 19, 2025, down 1.04% amid heavy trading. Kimberly-Clark’s pending cash-and-stock acquisition values Kenvue at about $18.35 per share, based on current prices, leaving a deal spread of roughly 7%. The merger awaits shareholder and regulatory approval, with legal risks and earnings pressure influencing the stock.
19 December 2025
··
Kenvue Stock (KVUE) Today: Latest News, Deal Outlook, Analyst Forecasts and Key Risks (Dec. 15, 2025)

Kenvue Stock (KVUE) Today: Latest News, Deal Outlook, Analyst Forecasts and Key Risks (Dec. 15, 2025)

Kenvue shares traded near $17.33 midday Monday, about 7% below the implied $18.59 value of Kimberly-Clark’s pending cash-and-stock offer. The gap reflects market uncertainty as the $48.7 billion deal awaits regulatory and shareholder approval, with closing expected in the second half of 2026. Kimberly-Clark shares stood at $103.15. New legal filings and shareholder law firm activity surfaced Monday.
15 December 2025
··
KVUE Stock Today (Nov. 22, 2025): Kenvue Rises as Kimberly‑Clark Deal, Dividend and Tylenol Ruling Shape Outlook

KVUE Stock Today (Nov. 22, 2025): Kenvue Rises as Kimberly‑Clark Deal, Dividend and Tylenol Ruling Shape Outlook

Kenvue shares closed at $16.64 in late Friday trading, up 3% on heavy volume, but still about 12% below the value implied by Kimberly-Clark’s takeover offer. The deal, announced November 3 and valued at $48–49 billion, would pay Kenvue holders $3.50 in cash plus 0.14625 KMB shares per KVUE share. Both boards approved the merger, expected to close in the second half of 2026.
22 November 2025
·
Kenvue (KVUE) Stock Plunges Amid Tylenol and Talc Fears – What’s Next?

KVUE Stock Today (Nov. 18, 2025): Shares Slip as Appeals Court Weighs Tylenol Cases; Dividend Cleared; Kimberly‑Clark Deal Spread Persists

Kenvue shares traded near $16.13 midday, down 0.7%, after a U.S. appeals court signaled it may revive over 500 Tylenol-autism lawsuits. A Texas judge declined to block Kenvue’s $398 million dividend, which remains set for Nov. 26. The pending Kimberly-Clark deal implies $18.83 per share for KVUE, about 14% above its current price. Volume reached 21.1 million shares by 17:32 UTC.
18 November 2025
·····
Kenvue (NYSE: KVUE) Stock Surges on $40B Buyout – Spin‑Off Saga, Tylenol Turmoil & Investor Outlook

Kenvue (NYSE: KVUE) Stock Surges on $40B Buyout – Spin‑Off Saga, Tylenol Turmoil & Investor Outlook

Kimberly-Clark agreed to acquire Kenvue for $48.7 billion on Nov. 3, 2025, a 46% premium to its prior close. Kenvue shares surged nearly 20% on the news, while Kimberly-Clark stock dropped 13%. The deal follows a turbulent year for Kenvue, including a CEO ouster, falling sales, and litigation over Tylenol safety claims. Kenvue posted $15 billion in 2025 revenue and maintained gross margins near 59%.
4 November 2025
···
Kenvue (KVUE) Stock Soars 20% on $48.7 B Buyout News – Q3 Earnings Beat and What’s Next

Kenvue (KVUE) Stock Soars 20% on $48.7 B Buyout News – Q3 Earnings Beat and What’s Next

Kimberly-Clark announced a $48.7 billion cash-and-stock deal to acquire Kenvue, sending Kenvue shares up about 20% in pre-market trading to near $17.50. Kenvue shareholders will receive $3.50 in cash and 0.14625 KMB shares per KVUE share. Kenvue reported Q3 net profit of $398 million, beating earnings expectations. Kimberly-Clark shares fell roughly 12.5% on the news.
3 November 2025
····
Investors Beware: 7 Stocks to Avoid on October 22, 2025 Amid Alarming Warnings

Investors Beware: 7 Stocks to Avoid on October 22, 2025 Amid Alarming Warnings

Netflix shares fell over 6% after missing earnings due to a Brazilian tax charge. Texas Instruments warned of weak demand, pushing its stock down 7.6% and dragging chipmakers lower. Target neared multi-year lows as sales dropped and its CEO resigned. The Buffett Indicator hit 219%, with top bankers warning of overvalued markets and possible correction.
22 October 2025
············
1 2 3

Stock Market Today

  • Ripple's Preliminary EU MiCA Approval Raises Questions on RLUSD and XRP Impact in Europe
    June 28, 2026, 12:06 PM EDT. Ripple received a preliminary Luxembourg crypto-asset service provider (CASP) license under the EU's Markets in Crypto-Assets (MiCA) framework, allowing it to offer regulated services across 30 EEA countries pending final conditions. Despite this regulatory milestone, investors remain cautious about the XRP token's value driver, as Ripple's license ownership does not directly translate to increased activity on the XRP Ledger (XRPL). While Ripple's regulated stablecoin RLUSD's supply declined over 30 days, XRPL stablecoin value grew by over 20%, challenging XRP's current $1.05 price near a $65.5 billion market cap. The EU's July 1, 2026, MiCA enforcement deadline heightens the license's strategic importance, but tangible XRP Ledger usage remains the critical question for investors assessing Ripple's European payments push.

Latest articles

MSFT rally set for Russell reshuffle as AI spending jitters hang over stock

MSFT rally set for Russell reshuffle as AI spending jitters hang over stock

28 June 2026
Microsoft (MSFT) surged 5.71% to $372.97 on record volume as FTSE Russell index changes moved the stock into both growth and value indexes, driving a “really massive trade” and “key liquidity day”; investors now face uncertainty over real demand versus index flows, with capex and AI spending weighing on future profitability.
Amazon (NASDAQ:AMZN) trades after Prime Day jump, AWS in focus as basket sizes shrink

Amazon (NASDAQ:AMZN) trades after Prime Day jump, AWS in focus as basket sizes shrink

28 June 2026
Amazon closed Friday at $232.69, up 2.5% on massive volume, but still down 4.8% from June 18; Prime Day U.S. sales jumped 9.3% to $26.4 billion as average order size fell 10.6%, while AWS will raise AI compute prices by about 20% in July, spotlighting investor focus on whether higher AWS pricing can offset soaring AI infrastructure costs.
Go toTop